Bradykinin	bradykinin	CHEMICALS	O	OTHERS	I
receptors	receptors	O	O	O	O
antagonists	antagonists	O	O	O	O
and	and	O	O	O	O
nitric	nitric	CHEMICALS	O	OTHERS	I
oxide	oxide	CHEMICALS	O	OTHERS	I
synthase	synthase	CHEMICALS	O	OTHERS	I
inhibitors	inhibitors	O	O	O	O
in	in	O	O	O	O
vincristine	vincristine	CHEMICALS	O	OTHERS	I
and	and	O	O	O	O
streptozotocin	streptozotocin	CHEMICALS	O	OTHERS	I
induced	induced	O	O	O	O
hyperalgesia	hyperalgesia	O	DISEASE	OTHERS	I
in	in	O	O	O	O
chemotherapy	chemotherapy	O	O	O	O
and	and	O	O	O	O
diabetic	diabetic	O	DISEASE	OTHERS	I
neuropathy	neuropathy	O	DISEASE	OTHERS	I
rat	rat	O	O	O	O
model	model	O	O	O	O
.	.	O	O	O	O

PURPOSE	purpose	O	O	O	O
:	:	O	O	O	O
The	the	O	O	O	O
influence	influence	O	O	O	O
of	of	O	O	O	O
an	an	O	O	O	O
irreversible	irreversible	O	O	O	O
inhibitor	inhibitor	O	O	O	O
of	of	O	O	O	O
constitutive	constitutive	O	O	O	O
NO	no	O	O	O	O
synthase	synthase	O	O	O	O
(	(	O	O	O	O
L-NOArg	l-noarg	O	O	O	O
;	;	O	O	O	O
1.0	1.0	O	O	O	O
mg/kg	mg/kg	O	O	O	O
ip	ip	O	O	O	O
)	)	O	O	O	O
,	,	O	O	O	O
a	a	O	O	O	O
relatively	relatively	O	O	O	O
selective	selective	O	O	O	O
inhibitor	inhibitor	O	O	O	O
of	of	O	O	O	O
inducible	inducible	O	O	O	O
NO	no	O	O	O	O
synthase	synthase	O	O	O	O
(	(	O	O	O	O
L-NIL	l-nil	O	O	O	O
;	;	O	O	O	O
1.0	1.0	O	O	O	O
mg/kg	mg/kg	O	O	O	O
ip	ip	O	O	O	O
)	)	O	O	O	O
and	and	O	O	O	O
a	a	O	O	O	O
relatively	relatively	O	O	O	O
specific	specific	O	O	O	O
inhibitor	inhibitor	O	O	O	O
of	of	O	O	O	O
neuronal	neuronal	O	O	O	O
NO	no	O	O	O	O
synthase	synthase	O	O	O	O
(	(	O	O	O	O
7-NI	7-ni	O	O	O	O
;	;	O	O	O	O
0.1	0.1	O	O	O	O
mg/kg	mg/kg	O	O	O	O
ip	ip	O	O	O	O
)	)	O	O	O	O
,	,	O	O	O	O
on	on	O	O	O	O
antihyperalgesic	antihyperalgesic	O	O	O	O
action	action	O	O	O	O
of	of	O	O	O	O
selective	selective	O	O	O	O
antagonists	antagonists	O	O	O	O
of	of	O	O	O	O
B2	b2	O	O	O	O
and	and	O	O	O	O
B1	b1	O	O	O	O
receptors	receptors	O	O	O	O
:	:	O	O	O	O
D-Arg-[Hyp3,Thi5,D-Tic7,Oic8	d-arg-[hyp3,thi5,d-tic7,oic8	O	O	O	O
]	]	O	O	O	O
bradykinin	bradykinin	CHEMICALS	O	OTHERS	I
(	(	O	O	O	O
HOE	hoe	O	O	OTHERS	I
140	140	O	O	OTHERS	I
;	;	O	O	O	O
70	70	O	O	O	O
nmol/kg	nmol/kg	O	O	O	O
ip	ip	O	O	O	O
)	)	O	O	O	O
or	or	O	O	O	O
des	des	CHEMICALS	O	OTHERS	I
Arg10	arg10	O	O	OTHERS	I
HOE	hoe	O	O	OTHERS	I
140	140	O	O	OTHERS	I
(	(	O	O	O	O
70	70	O	O	O	O
nmol/kg	nmol/kg	O	O	O	O
ip	ip	O	O	O	O
)	)	O	O	O	O
respectively	respectively	O	O	O	O
,	,	O	O	O	O
in	in	O	O	O	O
model	model	O	O	O	O
of	of	O	O	O	O
diabetic	diabetic	O	DISEASE	OTHERS	I
(	(	O	O	O	O
streptozotocin-induced	streptozotocin-induced	O	O	O	O
)	)	O	O	O	O
and	and	O	O	O	O
toxic	toxic	O	O	O	O
(	(	O	O	O	O
vincristine-induced	vincristine-induced	O	O	O	O
)	)	O	O	O	O
neuropathy	neuropathy	O	DISEASE	OTHERS	I
was	was	O	O	O	O
investigated	investigated	O	O	O	O
.	.	O	O	O	O

METHODS	methods	O	O	O	O
:	:	O	O	O	O
The	the	O	O	O	O
changes	changes	O	O	O	O
in	in	O	O	O	O
pain	pain	O	DISEASE	OTHERS	I
thresholds	thresholds	O	O	O	O
were	were	O	O	O	O
determined	determined	O	O	O	O
using	using	O	O	O	O
mechanical	mechanical	O	O	O	O
stimuli	stimuli	O	O	O	O
--	--	O	O	O	O
the	the	O	O	O	O
modification	modification	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
classic	classic	O	O	O	O
paw	paw	O	O	O	O
withdrawal	withdrawal	O	O	O	O
test	test	O	O	O	O
described	described	O	O	O	O
by	by	O	O	O	O
Randall-Selitto	randall-selitto	O	O	O	O
.	.	O	O	O	O

RESULTS	results	O	O	O	O
:	:	O	O	O	O
The	the	O	O	O	O
results	results	O	O	O	O
of	of	O	O	O	O
this	this	O	O	O	O
paper	paper	O	O	O	O
confirm	confirm	O	O	O	O
that	that	O	O	O	O
inhibition	inhibition	O	O	O	O
of	of	O	O	O	O
bradykinin	bradykinin	CHEMICALS	O	OTHERS	I
receptors	receptors	O	O	O	O
and	and	O	O	O	O
inducible	inducible	O	O	O	O
NO	no	O	O	O	O
synthase	synthase	O	O	O	O
but	but	O	O	O	O
not	not	O	O	O	O
neuronal	neuronal	O	O	O	O
NO	no	O	O	O	O
synthase	synthase	O	O	O	O
activity	activity	O	O	O	O
reduces	reduces	O	O	O	O
diabetic	diabetic	O	DISEASE	OTHERS	I
hyperalgesia	hyperalgesia	O	DISEASE	OTHERS	I
.	.	O	O	O	O

Pretreatment	pretreatment	O	O	O	O
with	with	O	O	O	O
L-NOArg	l-noarg	O	O	O	O
and	and	O	O	O	O
L-NIL	l-nil	O	O	O	O
but	but	O	O	O	O
not	not	O	O	O	O
7-NI	7-ni	O	O	O	O
,	,	O	O	O	O
significantly	significantly	O	O	O	O
increases	increases	O	O	O	O
antihyperalgesic	antihyperalgesic	O	O	O	O
activity	activity	O	O	O	O
both	both	O	O	O	O
HOE	hoe	O	O	OTHERS	I
140	140	O	O	OTHERS	I
and	and	O	O	O	O
des	des	CHEMICALS	O	OTHERS	I
Arg10	arg10	O	O	OTHERS	I
HOE	hoe	O	O	OTHERS	I
140	140	O	O	OTHERS	I
.	.	O	O	O	O

It	it	O	O	O	O
was	was	O	O	O	O
also	also	O	O	O	O
shown	shown	O	O	O	O
that	that	O	O	O	O
both	both	O	O	O	O
products	products	O	O	O	O
of	of	O	O	O	O
inducible	inducible	O	O	O	O
NO	no	O	O	O	O
synthase	synthase	O	O	O	O
and	and	O	O	O	O
neuronal	neuronal	O	O	O	O
NO	no	O	O	O	O
synthase	synthase	O	O	O	O
activation	activation	O	O	O	O
as	as	O	O	O	O
well	well	O	O	O	O
as	as	O	O	O	O
bradykinin	bradykinin	CHEMICALS	O	OTHERS	I
are	are	O	O	O	O
involved	involved	O	O	O	O
in	in	O	O	O	O
hyperalgesia	hyperalgesia	O	DISEASE	OTHERS	I
produced	produced	O	O	O	O
by	by	O	O	O	O
vincristine	vincristine	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

Moreover	moreover	O	O	O	O
,	,	O	O	O	O
L-NOArg	l-noarg	O	O	O	O
and	and	O	O	O	O
7-NI	7-ni	O	O	O	O
but	but	O	O	O	O
not	not	O	O	O	O
L-NIL	l-nil	O	O	O	O
intensify	intensify	O	O	O	O
antihyperalgesic	antihyperalgesic	O	O	O	O
activity	activity	O	O	O	O
of	of	O	O	O	O
HOE	hoe	O	O	OTHERS	I
140	140	O	O	OTHERS	I
or	or	O	O	O	O
des-Arg10HOE	des-arg10hoe	O	O	O	O
140	140	O	O	O	O
in	in	O	O	O	O
toxic	toxic	O	O	OTHERS	I
neuropathy	neuropathy	O	DISEASE	OTHERS	I
.	.	O	O	O	O

CONCLUSIONS	conclusions	O	O	O	O
:	:	O	O	O	O
Results	results	O	O	O	O
of	of	O	O	O	O
these	these	O	O	O	O
studies	studies	O	O	O	O
suggest	suggest	O	O	O	O
that	that	O	O	O	O
B1	b1	O	O	O	O
and	and	O	O	O	O
B2	b2	O	O	O	O
receptors	receptors	O	O	O	O
are	are	O	O	O	O
engaged	engaged	O	O	O	O
in	in	O	O	O	O
transmission	transmission	O	O	O	O
of	of	O	O	O	O
nociceptive	nociceptive	O	O	O	O
stimuli	stimuli	O	O	O	O
in	in	O	O	O	O
both	both	O	O	O	O
diabetic	diabetic	O	DISEASE	OTHERS	I
and	and	O	O	O	O
toxic	toxic	O	O	OTHERS	I
neuropathy	neuropathy	O	DISEASE	OTHERS	I
.	.	O	O	O	O

In	in	O	O	O	O
streptozotocin-induced	streptozotocin-induced	O	O	O	O
hyperalgesia	hyperalgesia	O	DISEASE	OTHERS	I
,	,	O	O	O	O
inducible	inducible	O	O	O	O
NO	no	O	O	O	O
synthase	synthase	O	O	O	O
participates	participates	O	O	O	O
in	in	O	O	O	O
pronociceptive	pronociceptive	O	O	O	O
activity	activity	O	O	O	O
of	of	O	O	O	O
bradykinin	bradykinin	CHEMICALS	O	OTHERS	I
,	,	O	O	O	O
whereas	whereas	O	O	O	O
in	in	O	O	O	O
vincristine-induced	vincristine-induced	O	O	O	O
hyperalgesia	hyperalgesia	O	DISEASE	OTHERS	I
bradykinin	bradykinin	CHEMICALS	O	OTHERS	I
seemed	seemed	O	O	O	O
to	to	O	O	O	O
activate	activate	O	O	O	O
neuronal	neuronal	O	O	O	O
NO	no	O	O	O	O
synthase	synthase	O	O	O	O
pathway	pathway	O	O	O	O
.	.	O	O	O	O

Therefore	therefore	O	O	O	O
,	,	O	O	O	O
concomitant	concomitant	O	O	O	O
administration	administration	O	O	O	O
of	of	O	O	O	O
small	small	O	O	O	O
doses	doses	O	O	O	O
of	of	O	O	O	O
bradykinin	bradykinin	CHEMICALS	O	OTHERS	I
receptor	receptor	CHEMICALS	O	OTHERS	I
antagonists	antagonists	CHEMICALS	O	OTHERS	I
and	and	O	O	O	O
NO	no	O	O	O	O
synthase	synthase	O	O	O	O
inhibitors	inhibitors	O	O	O	O
can	can	O	O	O	O
be	be	O	O	O	O
effective	effective	O	O	O	O
in	in	O	O	O	O
alleviation	alleviation	O	O	O	O
of	of	O	O	O	O
neuropathic	neuropathic	O	DISEASE	OTHERS	I
pain	pain	O	DISEASE	OTHERS	I
,	,	O	O	O	O
even	even	O	O	O	O
in	in	O	O	O	O
hospital	hospital	O	O	O	O
care	care	O	O	O	O
.	.	O	O	O	O

